下丘脑手术入路的系统综述:解剖通道与术后结局
该系统综述纳入27项研究共562例下丘脑手术患者,比较不同手术入路的解剖通道与临床结局。按病理分层,下丘脑错构瘤术后改善率74%,颅咽管瘤66.7%,胶质瘤44.2%。内镜入路改善率高于开放入路但死亡率更高,经胼胝体入路安全性最佳。
要点
- 内镜入路改善率88%高于开放61%,但死亡率3.0%高于0.5%。
- 眶颧入路较经胼胝体入路术后恶化风险和死亡率显著更高。
- 经胼胝体入路安全性最佳,眶颧入路应选择性使用。
核心结论
- 内镜入路临床改善率最高,经胼胝体入路安全性最佳。
- 颅底入路如眶颧入路并发症和死亡率更高,应选择性使用。
研究设计与样本
- 遵循PRISMA 2020指南的系统综述,检索PubMed和Scopus 2000年1月至2025年7月文献。
- 纳入27项研究共562例接受下丘脑手术的患者,采用随机效应模型进行荟萃分析。
主要发现
- 下丘脑错构瘤术后改善率74%(95%CI 0.640-0.838),颅咽管瘤66.7%(0.553-0.782),胶质瘤44.2%(0.288-0.596)。
- 内镜入路改善率88% vs 开放61%(OR 1.82,95%CI 0.95-3.50,P=0.072),死亡率3.0% vs 0.5%(OR 3.34,95%CI 1.18-9.48,P=0.023)。
- 眶颧入路较经胼胝体入路术后恶化风险更高(OR 3.36,95%CI 1.27-8.90,P=0.015),死亡率更高(OR 3.94,95%CI 1.49-10.46,P=0.006)。
- 翼点入路与经胼胝体入路在改善率(OR 1.59,95%CI 0.80-3.19,P=0.189)和死亡率(OR 2.33,95%CI 0.90-6.01,P=0.081)上无显著差异。
关键数值与推荐
- 内镜入路改善率88%,开放入路61%,OR 1.82(95%CI 0.95-3.50,P=0.072)。
- 内镜入路死亡率3.0%,开放入路0.5%,OR 3.34(95%CI 1.18-9.48,P=0.023)。
- 眶颧入路对比经胼胝体入路:术后恶化OR 3.36(95%CI 1.27-8.90,P=0.015),死亡OR 3.94(95%CI 1.49-10.46,P=0.006)。
- 翼点入路对比经胼胝体入路:改善OR 1.59(95%CI 0.80-3.19,P=0.189),死亡OR 2.33(95%CI 0.90-6.01,P=0.081)。
临床怎么用
- 下丘脑手术选择入路时应权衡改善率与死亡率,内镜入路改善率高但死亡率风险需关注。
- 经胼胝体入路安全性较好,可作为优先考虑的安全选择。
- 眶颧入路等颅底入路并发症和死亡率较高,应严格选择适应证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The hypothalamus is a vital neuroanatomical structure involved in endocrine, autonomic, and homeostatic regulation. Its deep location near critical neural and vascular structures makes surgical access complex. This review aims to evaluate and compare these surgical approaches, focusing on anatomical access and their clinical and functional outcomes. METHODS: This review was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines. A comprehensive search of PubMed and Scopus was performed for studies published between January 2000 and July 2025. Eligible studies included primary research on human patients undergoing surgical procedures targeting the hypothalamus. Where applicable, meta-analyses were conducted using random-effects models to pool outcome data and evaluate heterogeneity. RESULTS: Twenty-seven studies (n = 562) were included. By pathology, pooled postoperative improvement was 74% for hypothalamic hamartoma (95% confidence interval [CI] 0.640-0.838), 66.7% for craniopharyngioma (0.553-0.782), and 44.2% for glioma (0.288-0.596). Endoscopic approaches showed higher improvement than open surgery (88% vs. 61%; odds ratio [OR] 1.82, 95% CI 0.95-3.50, P = 0.072), but higher mortality (3.0% vs. 0.5%; OR 3.34, 95% CI 1.18-9.48, P = 0.023). Compared with the transcallosal (TC) route, the orbitozygomatic approach carried significantly greater risks of postoperative deterioration (OR 3.36, 95% CI 1.27-8.90, P = 0.015) and mortality (OR 3.94, 95% CI 1.49-10.46, P = 0.006); pterional versus TC differences were not significant for improvement (OR 1.59, 95% CI 0.80-3.19, P = 0.189) or mortality (OR 2.33, 95% CI 0.90-6.01, P = 0.081). CONCLUSION: Endoscopic approaches showed the highest clinical improvement, while TC routes offered the safest profile. Skull base approaches, such as orbitozygomatic, were associated with higher morbidity and should be used selectively.
引用
- Al-Juboori AA, Badran SA, Shahadha AA, et al. Surgical Approaches to the Hypothalamus: A Systematic Review of Anatomical Corridors and Postoperative Outcomes. World Neurosurg. 2025. PMID: 41276078. doi:10.1016/j.wneu.2025.124648
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。